BUSINESS
NOCIL: Strong pricing advantage; volume pick-up yet to be seen
While in the past few quarters, sales volumes have not picked up meaningfully, NOCIL is confident of hitting peak capacity utilisation by the end of H1FY24
BUSINESS
Ami Organics: New products to lead medium-term growth
The Ankleshwar facility expansion would enhance the capacity of pharma inter-mediates by 2.8 times. This would take care of the anticipated demand till FY27
BUSINESS
PPL IPO: Play on import substitution of non-urea fertilisers
PPL’s EV/EBITDA multiple of 5.6x is at a significant discount to its closest peer, Coromandel International, and closer to GSFC, which trails PPL in terms of return ratios by a margin.
BUSINESS
Balaji Amines: An eagle eye for import substitution opportunities
Balaji Amine’s project execution is worth noticing, due to which earnings potential has significantly increased over the years
BUSINESS
Cipla: Targets for US complex generics on track
Cipla is looking at launching inhalation product Advair in the second half of FY23
BUSINESS
Navin Fluorine: Multi-year contracts present a steady growth template
Navin Fluorine has posted a sequential improvement in sales, backed by high-value businesses – CRAMS and specialty chemicals.
BUSINESS
LTI-Mindtree merger: A complementary match
Post-merger, LTIMindtree will be the sixth-largest Indian IT company
BUSINESS
For the US Fed, 50 bps hikes are the new normal
The Fed’s balance sheet is likely to reduce by about $1 trillion in a year
BUSINESS
Apcotex: Medium-term opportunities priced in
Unstable macro and pricing environment are key risks to watch for Apcotex
BUSINESS
Atul: Focus is on enhancing vertical integration
Notwithstanding operational headwinds and higher working capital, Atul remains on track for a three-year capex cycle
BUSINESS
Rainbow IPO: A play on focused healthcare demand for children
Rainbow plans to add 500 beds/six hospitals in the next three years, with a focus on Hyderabad, Bengaluru, Chennai and NCR
BUSINESS
Bhansali Engineering: Delay in brownfield expansion caps volume growth; valuation fair
Import intensity across ABS value chain has reduced before the latest phase of lockdown in China and so it appears to be more a case of normalisation of channel inventory for Bhansali Engineering
BUSINESS
How much can PCBL tap into favourable supply-demand balance?
PCBL’s sequential sales growth of 5 percent was led by pricing growth, offsetting a 4 percent decline in volumes. This was chiefly due to supply-chain hurdles as export volumes were down 11 percent QoQ
BUSINESS
Kothari Petrochemicals: All set to harness capacity addition
Favorable supply-demand balance, new capacity and product diversification are key triggers to watch
MONEYCONTROL-RESEARCH
China’s macro blues: Lessons for investors
Underlying weakness in Chinese data, irrespective of COVID/lockdown is a key watch
BUSINESS
Alufluoride: Better equipped for the new journey ahead
Alufluoride poised for strong earnings growth aided by new contract cycle and new plant
BUSINESS
KIMS: A play on healthcare demand in the hinterland
The recent expansion tilt towards tier 2/3 cities suggests that this may garner decent volume growth, though possibly at the cost of margins
BUSINESS
Fed minutes: Strong signal of front-loading of tightening
A significant risk is that elevated inflation expectations could become entrenched if the public starts to question the committee’s resolve to achieve the 2 percent long-run target for inflation.
BUSINESS
Dr Reddy’s: Improving exposure to EMs adds to investment case
Situation in Russia presents an opportunity for Indian pharma companies to gain market share in Russia
BUSINESS
Will Powell pop the Volcker pill as stagflation risks rise?
Many view that monetary policy is ill-suited to deal with supply-side shocks — such as rising prices because of war, high energy prices, or supply chain disruptions
BUSINESS
Ami Organics: Niche chemistry and a strong export tailwind
Overall valuations, seen in the context of high growth and elevated margins, make Ami Organics a stock worth looking at
BUSINESS
Indian chemical industry in a sweet spot as Europe struggles
The ongoing energy crisis which disproportionately impacts Europe can further help Indian firms reach out to export markets of European chemical companies
BUSINESS
Fed: A plan for 10 rate hikes? What does it mean for global investors?
The hawkish stance on inflation reminds one of the early 80s, when Fed chair Paul Volcker clamped down on double-digit inflation
BUSINESS
Why you can look at this pharma value pick
A zero-debt company, Tyche continues to generate high free cash flow
